Arbor Research Collaborative for Health Awarded $1.2 Million Contract from CDC to Help Nursing Homes Use Electronic Health Records to Report Healthcare Acquired Infections

Arbor Research will work closely with the Centers for Disease Control and Prevention’s National Healthcare Safety Network to evaluate the ability of electronic health record (EHR) vendors to successfully implement and disseminate a standardized system for Clostridioides difficile infection (CDI) reporting into their EHR system, and assess the concordance of EHR versus manual-based reporting of CDIs by nursing homes.

Arbor Research Collaborative for Health to Serve on Team Evaluating the End-Stage Renal Disease Treatment Choices Model and the Kidney Care Choices Model

Arbor Research will collaborate with prime contractor Lewin Group, as well as with the University of Michigan Kidney Epidemiology and Cost Center and ICF to assess the effectiveness of each model.

PDOPPS: International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival

PDOPPS: International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival

The Dialysis Outcomes and Practice Patterns Study (DOPPS) Program at Arbor Research Collaborative for Health is pleased to announce the publication of our Peritoneal DOPPS manuscript titled, International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival describing international icodextrin prescription practices and their relationship to clinical outcomes.

Arbor Research Collaborative for Health Appoints Chris Spera, PhD as New President & CEO

Seasoned business leader and researcher, Chris Spera, Ph.D, takes the helm at Arbor Research, succeeding retiring president, Robert M. Merion, M.D. FACS.

Dr. Spera joins at the conclusion of a leadership transition process initiated last year by former President, Dr. Robert Merion and the Arbor Research Board of Directors. With Dr. Spera’s appointment, Dr. Merion takes on a new part-time role as a Distinguished Research Scientist, in which he can continue to impact outcomes research and the lives of patients.

RSS

Featured Articles

No content

A problem occurred while loading content.